ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $12,620,000 | +8369.8% | 181,131 | +2402.5% | 0.57% | +8014.3% |
| Q2 2021 | $149,000 | +210.4% | 7,238 | -19.6% | 0.01% | +250.0% |
| Q1 2021 | $48,000 | -94.0% | 9,000 | -71.5% | 0.00% | -96.2% |
| Q2 2020 | $795,000 | +609.8% | 31,587 | +435.4% | 0.05% | +766.7% |
| Q1 2020 | $112,000 | -37.8% | 5,900 | +73.5% | 0.01% | -45.5% |
| Q4 2019 | $180,000 | -38.4% | 3,400 | -54.1% | 0.01% | -59.3% |
| Q3 2019 | $292,000 | -20.0% | 7,400 | -16.9% | 0.03% | -20.6% |
| Q2 2019 | $365,000 | +69.8% | 8,900 | +17.1% | 0.03% | +54.5% |
| Q1 2019 | $215,000 | -1.8% | 7,601 | -57.5% | 0.02% | +4.8% |
| Q4 2018 | $219,000 | +298.2% | 17,901 | -0.6% | 0.02% | +425.0% |
| Q3 2018 | $55,000 | -20.3% | 18,000 | -14.3% | 0.00% | -20.0% |
| Q2 2018 | $69,000 | +245.0% | 21,000 | +727.1% | 0.01% | +400.0% |
| Q4 2017 | $20,000 | -70.1% | 2,539 | -71.5% | 0.00% | -50.0% |
| Q3 2017 | $67,000 | +55.8% | 8,910 | -51.3% | 0.00% | 0.0% |
| Q2 2017 | $43,000 | +43.3% | 18,300 | +7.6% | 0.00% | +100.0% |
| Q1 2017 | $30,000 | +328.6% | 17,000 | +507.1% | 0.00% | – |
| Q4 2016 | $7,000 | +133.3% | 2,800 | -3.4% | 0.00% | – |
| Q3 2016 | $3,000 | -25.0% | 2,900 | +163.6% | 0.00% | – |
| Q2 2016 | $4,000 | – | 1,100 | +10.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 1,000 | -76.9% | 0.00% | -100.0% |
| Q4 2015 | $22,000 | – | 4,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |